Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 3Unknown 1Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1Endocrine 1CNS 1

Conditions

Weight Loss 1Polycystic Ovary Syndrome 1Obesity 1Insulin Resistance 1Infertility, Female 1

Interventions

Metformin 6Psychiatric Rehabilitation 3Exercise 3Diet, Mediterranean 3Counseling 3Therapeutics 2Tamoxifen 2Surveys and Questionnaires 2Standard of Care 2Mammography 2Low-Level Light Therapy 2Early Intervention, Educational 2Dexamethasone 2semaglutide 1oxycodone-acetaminophen 1lime 1golotimod 1exemestane 1Utrogestan 1Uterine Myomectomy 1Tramadol 1Topiramate 1Tiotropium Bromide 1Thioctic Acid 1Testosterone 1Taxes 1Spironolactone 1Sexual Health 1Robotics 1Respiratory Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Liraglutide × Other × Clear all
NCT05952882 2023-10-23

Liraglutide and Metformin Combination on Weight Loss, Metabolic - Endocrine Parameters and Pregnancy Rate in Women With PCOS, Obesity and Infertility

Mỹ Đức Hospital

Phase 3 Unknown
188 enrolled
Other

Infertility, Female, Insulin Resistance, Obesity, Polycystic Ovary Syndrome, Weight Loss

Data powered by HemOnc (CC BY 4.0) Colophon ⚡